Clinical Trial Update: Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells [Phase 4]

View source ↗

Summary

Clinical trial update for PEG-rhG-CSF used to mobilize autologous hematopoietic stem cells in lymphoma patients (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Lymphoma | Phase 4 | Status: UNKNOWN